Heterotopic ossification, the pathologic formation of extraskeletal bone, occurs as a common complication of trauma or in genetic disorders and can be disabling and lethal. However, the underlying molecular mechanisms are largely unknown. Here we demonstrate that Ga s restricts bone formation to the skeleton by inhibiting Hedgehog signaling in mesenchymal progenitor cells. In progressive osseous heteroplasia, a human disease caused by null mutations in GNAS, which encodes Ga s , Hedgehog signaling is upregulated in ectopic osteoblasts and progenitor cells. In animal models, we show that geneticallymediated ectopic Hedgehog signaling is sufficient to induce heterotopic ossification, whereas inhibition of this signaling pathway by genetic or pharmacological means strongly reduces the severity of this condition. As our previous work has shown that GNAS gain-of-function mutations upregulate WNT-b-catenin signaling in osteoblast progenitor cells, resulting in their defective differentiation and fibrous dysplasia, we identify Ga s as a key regulator of proper osteoblast differentiation through its maintenance of a balance between the Wnt-b-catenin and Hedgehog pathways. Also, given the results here of the pharmacological studies in our mouse model, we propose that Hedgehog inhibitors currently used in the clinic for other conditions, such as cancer, may possibly be repurposed for treating heterotopic ossification and other diseases caused by GNAS inactivation. 
The human skeleton is a complex organ that forms during embryo genesis, grows during childhood, remodels throughout adult life and regenerates following injury. The spatial boundaries of its tem poral existence are tightly regulated. Extraskeletal, or heterotopic, ossification occurs sporadically or in several rare genetic disorders 1 . As in normal skeletal morphogenesis, heterotopic ossification can form through either an intramembranous or endochondral process, suggesting that multiple mechanisms are involved 1 . The cellular defect lies in aberrant cellfate determination of mesenchymal progenitor cells in soft tissues, resulting in inappropriate formation of chondro cytes, osteoblasts or both.
Heterotopic ossification is illustrated by two rare genetic disorders that are clinically characterized by extensive and progressive extra skeletal bone formation: fibrodysplasia ossificans progressiva (FOP) and progressive osseous heteroplasia (POH). In FOP (OMIM 135100), activating mutations in activin receptor type1, a bone morphogenetic protein type I receptor, induce heterotopic ossification through endo chondral ossification 2 . Ectopic bone morphogenetic protein (BMP) signaling induces ectopic chondrocyte differentiation before bone for mation, and heterotopic ossification is preceded by ectopic cartilage formation in FOP 3 . However, in POH (OMIM 166350) and Albright hereditary osteodystrophy (AHO, OMIM 103580), heterotopic ossifi cation occurs predominantly through an intramembranous process 4, 5 , and ectopic osteoblasts differentiate from mesenchymal progenitors independently of chondrocytes in these disorders. Clinically, POH presents during infancy with dermal and subcutaneous ossifications that progress during childhood into skeletal muscle and deep connec tive tissues (for example, tendons, ligaments and fascia). Over time, ectopic ossifications lead to ankylosis of affected joints and growth retardation of affected limbs. By contrast, ectopic bone formation in AHO presents later in life and is largely restricted to cutaneous and subcutaneous tissue 6 .
POH and AHO are caused by inactivating mutations in GNAS 4, 5, 7, 8 encoding Gα s , which transduces signals from G proteincoupled receptors (GPCRs). However, unlike the case with FOP, the molecular mechanism underlying POH and AHO remains unknown, as the connection between Gα s and a signaling pathway that is both necessary and sufficient to control intramembranous ossification has not been determined.
Gα s has emerged as a seminal regulator of mesenchymal pro genitors in the skeletal system. Activating mutations in GNAS cause fibrous dysplasia (OMIM 174800), in which osteoblast differen tiation from mesenchymal progenitors is impaired 9 . We have found previously that activated Gα proteins have important roles during skeletal development and in disease by modulating Wnt-βcatenin signaling strength 10 . The activating GNAS mutations that cause fibrous dysplasia potentiate Wnt-βcatenin signaling, and activa tion of Wnt-βcatenin signaling in osteoblast progenitors results in a fibrous dysplasia-like phenotype 10 . It is notable that neither POH nor AHO mirrors fibrous dysplasia phenotypically or molecularly. Removal of Gnas in mice weakened Wnt-βcatenin signaling and commitment of mesenchymal progenitors to the osteoblast lineage and bone formation 10, 11 . Therefore, weak Wnt-βcatenin signaling due to GNAS inactivation cannot be the cause of POH or AHO.
Gα s is a physiological activator of protein kinase A (PKA), an inhib itor of Hedgehog signaling that governs a wide variety of processes during development [12] [13] [14] . However, Hedgehog signaling has not been found to be required for intramembranous ossification as occurs in POH 15 . In addition, a causal link between Gα s and Hedgehog signaling has never been established in any genetic system [16] [17] [18] . Furthermore, although activated Gα i has been implicated in promoting Hedgehog signaling activity in Drosophila 19 , it is neither sufficient nor necessary for Hedgehog signaling, at least in vertebrates 20, 21 .
Traumaassociated nonhereditary heterotopic ossification is a common complication in adults 22 and remains a major unresolved medical challenge. Genetic forms of heterotopic ossification provide the opportunity to identify the molecular mechanisms whereby bone formation is spatially restricted. We therefore investigated which molecular pathways regulated by Gα s induce ectopic osteoblast differentiation in animal models of POH.
RESULTS

Loss of Gnas leads to POH-like skeletal anomalies
Unlike in patients with POH, heterozygous loss of Gnas function in Gnas +/− mice causes osteoma cutis, a cutaneous condition character ized by the presence of bone within the skin through an unknown mechanism, only late in life 23, 24 . Because heterotopic ossification in Gnas +/− mice lacks the two critical POH features of early onset and progressive invasion into deep tissues, we hypothesized that elimina tion of the other allele of Gnas was required to achieve this pheno type. Therefore, we completely removed Gnas in limb mesenchymal progenitor cells using the Prrx1-cre line. Whereas the Prrx1-cre; Gnas fl/+ mice appeared normal, homozygous loss of Gnas in the Prrx1-cre; Gnas fl/− or Prrx1-cre; Gnas fl/fl mice resulted in numerous skeletal anomalies, as well as severe and progressive heterotopic ossi fication resembling the phenotypes of POH (Fig. 1) . Gnas was effi ciently removed in the limbs, but not in the axial tissue, by Prrx1-cre at embryonic day 14.5 (E14.5), as assessed by mRNA expression, gene deletion in the genome and protein levels ( Supplementary Fig. 1a-c) . The Prrx1-cre; Gnas fl/− and Prrx1-cre; Gnas fl/fl mice showed similar phenotypes and were born with soft tissue syndactyly (webbing between the digits), fused joints and progressive heterotopic ossifi cation in soft tissues (Fig. 1) . Extraskeletal mineralization was first detected between E16.5 and E17.5, accelerated perinatally and was extensive by postnatal day 4 (P4). We observed heterotopic ossifica tion in the interdigital regions and between radius and ulna, which resulted in bone fusions by P4 (Fig. 1a,b) . Progressive mineralization continued to P20, when most mutant pups died with extensive bone and joint fusions and tendon mineralization (Fig. 1c,d) .
We observed similar heterotopic ossification phenotypes when we removed Gnas using either the Twist2-cre (here called Demo1-cre) or Tfap2a-cre (here called Ap2-cre) system, in which Cre excises Gnas more broadly in mesenchymal tissues outside of the limb (Supplementary Fig. 2a,b) . Therefore, Gnas is required in multiple mesenchymal tissues to suppress ectopic mineralization.
To demonstrate that ectopic mineralization is associated with osteo blast differentiation during ossification, we performed von Kossa staining and immunohistochemistry of the early osteoblast marker osterix 25 and the mature osteoblast marker osteocalcin (Fig. 1e,f and Supplementary Fig. 2c ). In P4 mutant limbs, von Kossa staining confirmed the presence of extensive mineralization in the Prrx1-cre; Gnas fl/fl mice (Fig. 1e) . We detected osterixpositive and osteocalcin positive cells in the ectopic bone tissues in both subcutaneous and interdigital regions, where ectopic cartilage was not found ( Fig. 1f and Supplementary Fig. 2c ). These data demonstrate that loss of Gnas in mesenchymal progenitor cells induces ectopic osteoblast differentiation through a progressive noncartilaginous intramembranous bone forma tion process. Thus, the Prrx1-cre; Gnas fl/− or Prrx1-cre; Gnas fl/fl mouse is a model of POH, and one that allows us to investigate the molecular and cellular mechanism of Gnas in restricting bone formation.
Loss of Gnas promotes ectopic osteoblast differentiation
Because heterotopic ossification often occurs in adults 22 , we inves tigated whether loss of Gnas in adult subcutaneous mesenchymal As weak Wnt-βcatenin signaling does not permit osteoblast differen tiation [26] [27] [28] [29] , it is unlikely that GNAS inactivation causes ectopic bone formation in POH or AHO by reducing the already diminished Wnt-β catenin signaling in soft tissue mesenchymal progenitor cells. To test whether Gα s may also regulate bone formation by regulating Hedgehog signaling, we asked first whether Gα s is a major regulator of Hedgehog signaling activity in vivo ( Fig. 3d-f ). We found that expression of Hedgehog target genes Ptch1, Gli1 and Hhip (which encodes Hedgehog interacting protein) was higher in the Prrx1-cre; Gnas fl/− limb at E14.5 as compared to control embryos, including in the interdigital areas, before heterotopic ossification appearance at E17.5, indicating that Hedgehog signaling was activated by loss of Gnas.
We then asked whether Gα s regulates Hedgehog signaling by regu lating PKA. In SMPs and BMSCs lacking Gnas, although cAMP levels and PKA activities (assayed by Creb phosphorylation) were also lower compared to control cells containing Gnas, Hedgehog signaling was higher, as indicated by expression of Ptch1, Gli1 and Hhip (Fig. 4a-c) . However, Wnt signaling was weaker in the Gnasdeficient cells, as indicated by lower expression of the Wnt-βcatenin target genes Axin2, Tcf1 and Lef1 and βcatenin protein levels 30 ( Supplementary  Fig. 4e-f) . In vivo, Wnt-βcatenin target gene expression and Fig. 3 ). We detected extensive heterotopic ossification 6 weeks after injection by the pres ence of ectopic osteoblasts and mineralization in the dermal and sub cutaneous regions injected with AdCre but not AdGFP (Fig. 2a,b) . This finding demonstrates that loss of Gnas in adult subcutaneous mesenchymal tissues is sufficient to cause heterotopic ossification similar to that found in POH and AHO. Notably, as has been found in patients with POH, such induced heterotopic ossification was progres sively more severe and invaded deep muscular tissues when more time was allowed for development of heterotopic ossification (Fig. 2c,d ).
To test whether heterotopic ossification results from ectopic osteoblast differentiation of mesenchymal progenitors cells, we iso lated bone marrow stromal cells (BMSCs) and subcutaneous mesen chymal progenitors (SMPs) from the Gnas fl/fl mice and infected them with AdCre to remove Gnas. We observed efficient Gnas deletion ( Supplementary Fig. 1d-f) . AdCre-infected BMSCs (Fig. 3a,b) and SMPs (Supplementary Fig. 4a) showed accelerated osteogenic differentiation, as demonstrated by enhanced mineralized matrix formation. This was confirmed by higher expression of osteoblast differentiation markers such as osterix, collagen 1a1, alkaline phos phatase, bone sialoprotein and osteocalcin in BMSCs infected with AdCre compared to those infected with AdGFP (Fig. 3c) .
Gnas is required to inhibit Hedgehog signaling
We have found previously that the activating GNAS mutations causing fibrous dysplasia potentiate Wnt-βcatenin signaling 10 . npg βcatenin protein levels were lower in the Prrx1-cre; Gnas fl/− limb at E14.5 as compared to control embryos ( Supplementary Fig. 5a,b) . Blocking cAMP degradation with isobutylmethylxanthine (IBMX) 31 or activating cAMP production with forskolin 32 rescued the effects caused by Gnas removal (Fig. 4d-f) . Furthermore, expression of a dominantnegative form of PKA (dnPKA) mimicked the effects of Gnas removal (Fig. 4g-j) . Therefore, Gα s acts through cAMP and PKA to modulate Hedgehog signaling strength. Regulation of Hedgehog signaling by Gnas was further confirmed by strong genetic interactions (i.e., the double mutant phenotype is enhanced compared to either of the single mutants) between Gnas and Ptch1 (Supplementary Fig. 5c-g ). Ptch1 is an inhibitor of the Hedgehog pathway, and Ptch1 +/− mice provide a sensitized genetic background to test other suppressors of Hedgehog signaling 33 . Ptch1 heterozygosity enhanced the phenotypes caused by Dermo1 Cre-induced or Ap2Cre-induced Gnas removal in Gnas fl/fl mice ( Supplementary Fig. 5c-g ), indicating that an important in vivo function of Gnas is suppression of Hedgehog signaling. We further tested this in the developing neural tube, where the Hedgehog signal ing gradient patterns the dorsalventral axis 34 . In Gnas −/− embryos, which died at E9.5, Hedgehog target gene expression was higher com pared to that in control embryos, whereas Wnt target gene expres sion was lower, and the neural tube was ventralized ( Supplementary  Fig. 6a-c) . These defects phenocopied mutant embryos resulting from loss of Hedgehog signaling inhibitors such as PKA, Ptch1 and suppressor of fused 13, 33, 35 . In contrast, inhibiting Gα i family mem bers by expressing pertussis toxin had no effect on limb patterning, skeletal development or Hedgehog signaling activity ( Supplementary  Fig. 6d,e) . Thus, Gα s , but not Gα i , is a required in vivo regulator of Hedgehog signaling in multiple tissues and at multiple stages of development.
Hedgehog exerts its biological activity by altering the balance between activator (full length) and repressor (truncated) forms of the Gli family of zincfinger transcription factors (Gli A and Gli R , respectively) 36 . Increased Gli A and reduced Gli R expression indicate Hedgehog pathway activation 37 . In vertebrates, Gli R function is largely derived from Gli3, whereas the primary Gli A activity is mostly from Gli2. Expression of Hedgehog target genes requires Gli A function. As PKA regulates both Gli3 processing and Gli2 activation 13 (Supplementary Fig. 7a ), forskolin potently sup pressed elevated Hedgehog signaling in the Prrx1-cre; Gnas fl/− limb (Supplementary Fig. 7b ). Given that Gli2 is required for ventral neu ral tube patterning 40, 41 , expansion of the ventralmost neural tube marker expression in the Gnas −/− embryos (Supplementary Fig. 6c ) indicated that Gli2 is activated by loss of Gnas. In addition, fulllength Gli3 (Gli3 A ) and Gli2 levels were higher and Gli3 R levels were lower in the limb bud of Prrx1-cre; Gnas fl/− mice relative to littermate con trols (Supplementary Fig. 7c,d) . Taken together, our data indicate that Gα s suppresses Hedgehog signaling by regulating Gli activation and processing through PKA.
Consistent with this notion, in the limb bud culture we found that cyclopamine, an inhibitor of the Hedgehog receptor Smoothened (Smo) 42 , could not suppress Hedgehog target gene expression in Gnas deficient limbs, whereas the Gli inhibitors arsenic trioxide (ATO) 43 and GANT58 (ref. 44) , smallmolecule antagonists of Gli transcrip tion factors, could (Supplementary Fig. 7b ). These results indicate that Gα s acts downstream of Smo and upstream of Gli transcription factors to suppress Hedgehog signaling in embryonic limbs.
Active Hedgehog signaling causes heterotopic ossification
Gli2 mainly functions as a Gli A that transduces Hedgehog signal ing 45, 46 . To test whether activated Hedgehog signaling is essential in inducing heterotopic ossification, we removed Gli2 in Prrx1-cre; (Fig. 5a) . Loss of both copies of Gli2 further ameliorated ectopic mineralization, particularly in the hindlimb, where the mutant pheno types of heterotopic ossification, syndactyly and joint fusion were almost completely rescued (Fig. 5a) . We also achieved amelioration of heterotopic ossification by injecting pharmacologic inhibitors of Gli, ATO or GANT58 into female mice pregnant with Prrx1-cre; Gnas fl/− pups (Fig. 5b) . Whereas higher and more frequent doses of these compounds are required to inhibit Hedgehogdriven tumor growth in adult mice 43, 44 , similar dosing in pregnant female mice led to spontaneous abortion, precluding their use in this model. In addition to the in vivo effect of GANT58, we also observed inhibition of osteoblast differentiation by GANT58 in vitro in Gnas-deficient BMSCs ( Fig. 5c and Supplementary Fig. 7e ). Taken together, these data demonstrate that Hedgehog signaling activation is required for osteoblast differentiation driven by loss of Gnas func tion in mesenchymal progenitors.
To test whether Hedgehog signaling is upregulated in patients with POH, we performed GLI1 and GLI2 immunohistochemistry on heterotopic ossification samples from two individuals with POH 7 , GLI1 and GLI2 expression was present in hair follicles, where Hedgehog signaling is active under normal conditions ( Supplementary  Fig. 7f,g ). In the POH samples, GLI1 and GLI2 expression was also present in cells within the ectopic bone tissue (Fig. 6a-c and  Supplementary Fig. 7g) . The most intense detection of staining for GLI1 and GLI2 was along the surface of the ectopic bone, suggesting that Hedgehog signaling is most highly upregulated at the leading edge of new bone formation that contains boneforming progenitor cells. This is consistent with our in vitro data showing that Hedgehog signaling is highly upregulated in progenitor cells just before osteob lastic differentiation (Fig. 3f) . In the limbs of Prrx1-cre; Gnas fl/fl mice at P4, loss of Gnas led to upregulated Gli1 protein expression in most cells compared to the wildtype control (Supplementary Fig. 8a ). We also found that areas of adipose tissue appeared to contain occa sional GLI1positive cells (Fig. 6c) , which suggests these cells are npg a r t i c l e s potential osteoprogenitor cells within the subcutaneous fat tissue. These findings support that upregulated Hedgehog signaling also drives ectopic bone formation in the human disease.
To test whether Hedgehog signaling activation alone is sufficient to cause heterotopic ossification, we injected AdCre subcutaneously into the limbs of the adult R26SmoM2 mice 47 , in which an activated form of Smo (SmoM2) is expressed following Cremediated recombination. Eight weeks after AdCre injection, but not AdGFP injection, we readily detected heterotopic ossification (Fig. 6d) . BMSCs and SMPs from the R26SmoM2 mice also showed upregulated Hedgehog signal ing and accelerated osteoblast differentiation after AdCre infection ( Fig. 6e and Supplementary Fig. 8b-d) . These results demonstrate that Hedgehog signaling activation is both necessary and sufficient to induce heterotopic ossification and that Hedgehog signaling must be actively suppressed by Gα s to ensure spatial restriction of bone formation to the normal skeleton.
DISCUSSION
Here we show that loss of Gnas causes heterotopic ossification by activating Hedgehog signaling. Further, we provide evidence that previously identified Hedgehog signaling inhibitors, particularly Gli inhibitors that have been developed for cancer therapy, may be repurposed to treat heterotopic ossification and possibly other dis eases caused by reduction of Gα s activity. This work, together with our previous study 10 , provides deep mechanistic insights into how gainoffunction and lossoffunction mutations of the same GNAS gene cause completely different diseases (fibrous dysplasia and POH, respectively) by identifying distinct downstream pathways (Wnt-β catenin and Hedgehog) that primarily mediate these effects. As both high and low Gα s signaling causes bone diseases, our work highlights the necessity of tightly regulating Gα s activities by GPCRs both spa tially and temporally. As there are a large number of GPCRs and their ligands, it would not be surprising that mutations disrupting a single GPCR or the production of one class of GPCR ligands result in less pronounced alteration in Hedgehog or Wnt signaling compared to altered expression of a common downstream effector, such as Gα s , and therefore cause less severe phenotypes. Consistent with this, it has been found that loss of a GPCR, Gpr161, which has no known ligand, causes milder developmental defects in mouse embryos 48 compared to those we observed in the Gnas −/− mutant embryos in our study.
As a critical regulator of osteoblast differentiation from mesen chymal progenitor cells, Gα s functions by modulating the signaling activities of Wnt-βcatenin and Hedgehog, both of which are key signaling pathways that have fundamental roles in skeletal develop ment and disease 49 . Activation or inactivation of GNAS causes upregulation of only one of the two pathways, indicating that one function of Gα s in mesenchymal progenitor cells is to maintain a criti cal balance between Wnt-βcatenin and Hedgehog signaling, which is required for proper osteogenesis and its spatial regulation. Only appropriate levels of Hedgehog and Wnt signaling, as determined by a specific range of Gα s activities (shown by the box in Fig. 6f) , result in normal bone formation. Outside the boxed range, extreme Wnt or Hedgehog signaling either inhibits bone formation in the skeleton or causes ectopic bone formation in soft tissues. Therefore, it is likely that distinct mutations in GNAS cause corresponding bone diseases such as fibrous dysplasia and POH by altering the balance to enhance either Wnt-βcatenin or Hedgehog signaling, respectively (Fig. 6f) .
Genetic studies have shown that Wnt signaling acts permissively for osteoblast differentiation. Osteoblast differentiation is favored when Wnt signaling is above a threshold level [26] [27] [28] 50, 51 . Therefore, Wnt signaling alteration itself primarily affects bone formation in the normotopic skeleton and cannot cause ectopic bone formation unless an inducer of osteoblast differentiation is present. Here we identify Hedgehog signaling as one such inducer. In the POH mouse model, lower Wnt signaling was not sufficient to inhibit ectopic bone formation promoted by ectopic Hedgehog signaling. It is important to note that overactivative Wnt signaling also inhibits osteoblast differentiation 10, [52] [53] [54] [55] [56] . This, together with lower Hedgehog signal ing, explains the phenotype of fibrous dysplasia. As both Wnt and Hedgehog signaling pathways have potent regulatory activities, some reduction of their normal signaling levels can be tolerated, whereas ectopic signaling causes deleterious effects. Therefore, the disease phenotypes at the tissue and cellular levels are primarily determined by the pathway that is activated. As Wnt and Hedgehog signaling are both required to regulate a diverse array of develop mental and physiological processes, our finding that their balance is regulated by Gnas provides a conceptual framework for understand ing the molecular and cellular mechanisms of skeletal and possibly other diseases.
Our studies show that ectopic bone in soft tissues forms by dif ferentiation of osteoblast cells from mesenchymal progenitor cells. Even when Gnas is removed uniformly in early limb buds, as in the Prrx1-cre; Gnas fl/− mice, later heterotopic ossification progresses from the distal limb ( Fig. 1) , which contains more progenitor cells than the proximal limb 57, 58 . Ligand-mediated Hedgehog signaling is only required for endochondral bone formation 15 , raising the possibility that intramembranous bone formation in the skull may be promoted by ligandindependent activation of Hedgehog signaling. Our find ing that Hedgehog signaling activation due to loss of Gα s signaling is both necessary and sufficient for heterotopic ossification through the intramembranous mechanism suggests that this signaling crosstalk may also be important in physiological bone formation and homeos tasis. For instance, defective GPCRGα s signaling may cause impaired development of cranial and clavicle bones. Furthermore, it would be interesting to determine whether the appearance of extraskeletal dermal bone, which is physiologically important in some species, for example, the armadillo, is caused by alteration in the GPCRGα s Hedgehog signaling axis during evolution.
The mosaic nature of heterotopic ossification in POH and AHO suggests that the mild elevation of basal Hedgehog signaling in these patients provides a sensitized tissue background for ectopic osteoblast differentiation that occurs when additional Hedgehog signaling or other osteogenic factors are provided by a local micro environment. For instance, elevated Hedgehog signaling in the hair follicle may trigger heterotopic ossification in the subcutaneous region in patients with POH and AHO.
Nonhereditary forms of heterotopic ossification often contain a mixture of both cartilage and bone. It is possible that the underlying molecular mechanisms of nonhereditary forms of heterotopic ossifi cation are a combination of those underlying POH and FOP. In fact, the developmental program of ectopic chondrogenesis orchestrated by dysregulated bone morphogenetic protein signaling also upregulates Hedgehog signaling at ectopic sites 59 . Therefore, combining Hedgehog inhibitors and the nuclear retinoic acid receptorγ agonists 60 , which block chondrogenesis, may be a promising strategy for POH, as well as common, nonhereditary forms of heterotopic ossification.
METHODS
Methods and any associated references are available in the online version of the paper. 
